Anson Funds Management LP Summit Therapeutics Inc. Transaction History
Anson Funds Management LP
- $663 Million
- Q2 2024
A detailed history of Anson Funds Management LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 941,908 shares of SMMT stock, worth $30.1 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
941,908Holding current value
$30.1 Million% of portfolio
1.11%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
138Shares Held
64.4MCall Options Held
1.06MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$741 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$282 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$252 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$132 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$94.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $6.42B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...